SARS-CoV-2 vaccines

We are the Borg.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Vaccine found 92% effective in Israel, in first controlled result outside trials

Only 31 out of 163,000 fully vaccinated Maccabi members caught virus, indicating Pfizer shots living up to expectations; expert: Results ‘well within expected standard deviation’

A medical worker prepares a COVID-19 vaccine in Kiryat Ye'arim, on January 25, 2021. (Yonatan Sindel/Flash90)

Pfizer’s coronavirus vaccine is showing 92 percent effectiveness in Israel, according to the world’s first big controlled investigation on how it works outside of clinical tests.

Only 31 out of 163,000 Israelis vaccinated by Maccabi Healthcare Services were diagnosed with COVID-19 in their first 10 days of full-strength protection, its top vaccine statistics analyst, Anat Ekka Zohar, told The Times of Israel on Thursday.

Maccabi found that an equivalent sample of unvaccinated Israelis was 11 times more likely to be diagnosed with the coronavirus, which allowed it to calculate the effectiveness rate.

“This is very, very good news,” Ekka Zohar said. “It is the first study in the world that looks at such a large number of fully vaccinated patients.”

Pfizer achieved 95% efficacy in clinical trials, and doctors worldwide are looking to Israel with bated breath to see whether the vaccine comes close to that figure in real-world use.
https://www.timesofisrael.com/vaccine-f ... de-trials/
Pyrrho
Posts: 31974
Joined: Sat Jun 05, 2004 2:17 am
Title: Man in Black
Location: Division 6

Re: SARS-CoV-2 vaccines

Post by Pyrrho »

https://www.npr.org/sections/coronaviru ... re-covid-1
A global study of nearly 44,000 found that the COVID-19 vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease.

The study was conducted in the U.S., Latin America and South Africa. The vaccine did better at preventing disease in this country – 72% percent — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Backlash grows for ‘selfish millionaire’ who got vaccine meant for Indigenous people

Canadian casino executive Rodney Baker and his wife were initially fined C$2,300 for breaking public health rules

A millionaire Canadian couple who traveled to a remote community to receive a coronavirus vaccine intended for vulnerable and elderly Indigenous people are facing growing calls for a tougher punishment after they were initially fined C$2,300 (US$1,800) for breaking public health rules.

Casino executive Rodney Baker and his wife Ekaterina Baker, an actor, travelled by chartered plane to Beaver Creek, a community of 100 in Canada’s Yukon territory, where a mobile team was administering the Moderna vaccine to locals, including elderly members of the White River First Nation.

At the mobile clinic, the Bakers posed as local motel employees to receive the vaccine, officials allege. They were detained at the airport in Whitehorse, the territorial capital, as they traveled home to Vancouver, British Columbia.

The couple were fined for violating Yukon’s Civil Emergency Measures Act, but local community leaders argue that the fine will mean little to the wealthy couple.
https://www.theguardian.com/world/2021/ ... ns-scandal

NJ hospital gave vaccine to wealthy donors, ineligible relatives in December

RARITAN TOWNSHIP — Weeks before the state began opening eligibility to the general public, a hospital in Hunterdon County was handing out the coveted COVID-19 vaccine to deep-pocketed donors and the relatives of its executives.

And while vulnerable senior citizens wondered when it would be their turn, recipients of the vaccine at Hunterdon Medical Center included officials' young-adult children who were able to get the shot at a time when only front-line healthcare workers and long-term care residents could.

The line-cutting at the hospital was revealed by vaccine registry information that a whistleblower provided to New Jersey 101.5, demonstrating that despite the state's plan for an "equitable" distribution of the vaccine, those with privilege are managing to get it anyway.

More than a month after a connected few with ties to Hunterdon Medical Center, Hunterdon Healthcare and the Hunterdon Healthcare Foundation received their vaccines, fewer than 630,000 people have been vaccinated in a state with more than 6.3 million adults. About 5% of the recipients in New Jersey have been Latino and just 3% have been Black. Just under a third of the supply has gone to those over 65, the most vulnerable population.
https://nj1015.com/hunterdon-medica-cen ... 9-vaccine/

'Paramedic of the Year' in Florida arrested for alleged role in theft of Covid-19 vaccines

Joshua Colon, a paramedic for the Polk County Fire Rescue, faces charges for his alleged role in helping a supervisor steal doses of the Moderna vaccine.

A Florida man who was named 2020 paramedic of the year admitted to investigators that he played a role in the alleged theft of coronavirus vaccine doses, the Polk County Sheriff said on Tuesday.

Joshua Colon, 31, was arrested on Monday and faces forgery, fraud and misconduct charges after he admitted to forging paperwork to cover up what he said was a supervisor's theft of three pre-filled syringes of the Moderna Covid-19 vaccine.

In a press conference, Polk County Sheriff Grady Judd said that authorities noticed there were "discrepancies" and "total confusion" on three different vaccine forms filled out by Colon, who had been given three full vials of the vaccine on Jan. 6 to administer to Polk County first responders.

Authorities contacted several of the names of vaccine recipients on the forms and found that they were former firefighters who said they had never received any doses.

Judd said that the 2020 Paramedic of the Year later "confessed" and began to cooperate with investigators, admitting to using false names for "fraudulent" and "wrong" reasons.

Colon said he did so at the behest of his supervisor, Polk County Fire Rescue Captain Anthony Damiano.
https://www.nbcnews.com/news/us-news/pa ... s-n1255701
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Covid vaccines are slowing spread of virus already, early study shows

Vaccination is already easing Britain’s Covid epidemic with early data showing it is definitely reducing cases.

Research due to be published within days will provide real-world evidence that Britons are being protected, including suggestions that the effect is still building a month after one dose, said Anthony Harnden, deputy chairman of the Joint Committee on Vaccination and Immunisation (JCVI).

With fears about an EU export ban on vaccines, Professor Harnden said plans were in place for people to be able to mix and match vaccines if second doses of the Pfizer jab were unavailable.

Decisions on vaccinating teachers and other key workers in the second phase are likely to involve political and economic input because clear evidence that the vaccines block transmission of the virus is unlikely to be available for months, he said.
https://www.thetimes.co.uk/article/covi ... lbwwgsvrh/
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

The vaccine news continues to be better than many people realize.

The news about the vaccines continues to be excellent — and the public discussion of it continues to be more negative than the facts warrant.

Here’s the key fact: All five vaccines with public results have eliminated Covid-19 deaths. They have also drastically reduced hospitalizations. “They’re all good trial results,” Caitlin Rivers, an epidemiologist at Johns Hopkins University, told me. “It’s great news.”

Many people are instead focusing on relatively minor differences among the vaccine results and wrongly assuming that those differences mean that some vaccines won’t prevent serious illnesses. It’s still too early to be sure, because a few of the vaccine makers have released only a small amount of data. But the available data is very encouraging — including about the vaccines’ effect on the virus’s variants.
...
[...] all five of the vaccines — from Pfizer, Moderna, AstraZeneca, Novavax and Johnson & Johnson — look extremely good. Of the roughly 75,000 people who have received one of the five in a research trial, not a single person has died from Covid, and only a few people appear to have been hospitalized. None have remained hospitalized 28 days after receiving a shot.

To put that in perspective, it helps to think about what Covid has done so far to a representative group of 75,000 American adults: It has killed roughly 150 of them and sent several hundred more to the hospital. The vaccines reduce those numbers to zero and nearly zero, based on the research trials.

Zero isn’t even the most relevant benchmark. A typical U.S. flu season kills between five and 15 out of every 75,000 adults and hospitalizes more than 100 of them.
https://www.nytimes.com/2021/02/01/brie ... olice.html
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest

After criticism last year for an early rollout, Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19 and 100% effective against severe and moderate disease, according to an interim analysis of the vaccine's Phase 3 trial results.
The preliminary findings were published in The Lancet on Tuesday and are based on data gathered from 19,866 participants, of which around three-quarters (14,964) received two doses of the vaccine and a quarter (4,902) were given a placebo.
Sixteen cases of symptomatic Covid-19 were confirmed in the vaccine group 21 days after participants received the first vaccine dose. Sixty two cases were found in the placebo group -- equating to an efficacy of 91.6%.

The trial included 2,144 people over the age of 60 and a sub-analysis conducted on this group revealed the vaccine was well tolerated and had a similar efficacy of 91.8%.
The team also analyzed the efficacy of the vaccine against severe and moderate Covid-19 disease and 21 days after the first dose no severe or moderate cases were reported in the vaccinated group, while 20 were reported in the placebo group.
Serious adverse events were also rare and none was considered to be associated with vaccination. The majority of side-effects that were reported were mild, such as pain at the injection site, flu like symptoms and low energy levels, according to the study.
The analysis includes only symptomatic cases of Covid-19, however, and the authors note more research is needed to understand the vaccine's efficacy against asymptomatic Covid-19, transmission and how long protection may last.
https://edition.cnn.com/2021/02/02/heal ... index.html
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

An interesting read:
Myths of Vaccine Manufacturing
Rob Lister
Posts: 23535
Joined: Sun Jul 18, 2004 7:15 pm
Title: Incipient toppler
Location: Swimming in Lake Ed

Re: SARS-CoV-2 vaccines

Post by Rob Lister »

Anaxagoras wrote: Wed Feb 03, 2021 12:32 pm An interesting read:
Myths of Vaccine Manufacturing
Derek rocks.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Pfizer says its Covid-19 vaccine will bring in $15 billion this year.

The drug maker Pfizer expects its Covid-19 vaccine to generate $15 billion in revenue this year, executives said Tuesday on a call with investors to discuss the company’s fourth-quarter earnings in 2020.

Pfizer and other companies have struggled to keep up with the demand for their vaccines, as the United States and countries around the world are scrambling to vaccinate as many people as possible to combat the spread of more contagious variants.

In comments to investors on Tuesday, the company’s chief executive, Dr. Albert Bourla, said Pfizer had delivered 29 million doses to the United States by the end of January, and 65 million doses worldwide, and that it expected to manufacture up to 2 billion doses by the end of the year. It shares profits with BioNTech, the German company that developed the vaccine.

Dr. Bourla also said Pfizer now expects to deliver the 200 million doses, for about $4 billion, that it had promised to the United States two months ahead of time, by May instead of July. That accelerated timeline can be attributed in large part to Pfizer now counting six doses in every vial of vaccine that it ships instead of five — after health care providers learned they could extract an additional dose using special syringes.

“We foresee no issues with delivering the commitments we have made,” Dr. Bourla said.

And, in an indication that the coronavirus may be here to stay, Dr. Bourla said he expects the vaccine to become a standard part of its business, given the likely need for booster shots to address waning immunity to the virus as well as variants that could reduce its effectiveness.

Pfizer has said that preliminary tests of its vaccine against more contagious variants have shown that it continues to be effective, but suggested that a third shot of the same vaccine may be needed, and the company has also not ruled out changing its vaccine to address the new variants. Moderna, which has developed a similar vaccine, has said it is already working on an adapted booster shot.
https://www.nytimes.com/live/2021/02/02 ... us-vaccine
sparks
Posts: 17370
Joined: Fri Oct 26, 2007 4:13 pm
Location: Friar McWallclocks Bar -- Where time stands still while you lean over!

Re: SARS-CoV-2 vaccines

Post by sparks »

The world is dying yet, business as usual.

Why am I not surprised?
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

Bill Gates' annual letter, if anyone's interested:

https://www.gatesnotes.com/2021-Annual- ... tIQAvD_BwE

He has a short video too.

Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose
Analyses reveal single standard dose efficacy from day 22 to day 90 post vaccination of 76% with protection not falling in this three-month period
So, this is referring to just one single dose of the AZ vaccine.

The UK is taking an approach of delaying the second dose until 12 weeks after the first one, I believe, so as to allow more people to get that first dose faster. I guess 12 weeks would be 84 days technically, but they are counting up to 90 days.
After the second dose vaccine efficacy from two standard doses is 82.4% with the 3-month interval being used in the UK. (82.4% effective, with a 95% confidence interval of 62.7% - 91.7% at 12+ weeks)
Data supports the 4-12 week prime-boost dosing interval recommended by many global regulators
Analyses of PCR positive swabs in UK population suggests vaccine may have substantial effect on transmission of the virus with 67% reduction in positive swabs among those vaccinated
Researchers at the University of Oxford have today published in Preprints with The Lancet an analysis of further data from the ongoing trials of the vaccine. In this, they reveal that the vaccine efficacy is higher at longer prime-boost intervals, and that a single dose of the vaccine is 76% effective from 22- to up to 90-days post vaccination.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Not a vaccine, but interesting if it works as advertised:
Israeli hospital says it may have found Covid-19 cure as all treated patients make full recovery

A number of severely ill Covid-19 patients made a full recovery within five days after being treated with a relatively unknown cancer drug, according to multiple media reports in Israel today.

Researchers at the Ichilov Hospital in Tel Aviv told Israeli’s KAN News network that out of 30 seriously ill Covid-patients that were treated with the drug, 29 showed a significant improvement within two days and all were released within three to five days.

One patient ultimately did recover but this took “a few days” longer, according to the hospital’s Covid-19 lead, professor Nadir Arber.

The medication, called EXO-CD24, is a targeted drug that was reportedly developed as a cure for certain types of cancer.

Ichilov hospital decided to administer the drug to 30 moderate-to-seriously ill Covid-19 patients, which led to a success rate of 96% within a set trial period of five days, explained Arber, who is part of the hospital’s Integrated Cancer Prevention Centre.

EXO-CD24 is relatively inexpensive and must be given once a day for a period of five days. It fights the cytokine storm, a potentially lethal immune overreaction as a result of a coronavirus infection, which is believed to be responsible for many Covid-related deaths.

The drug uses so-called ‘exosomes’ – tiny carrier pouches that shuttle materials between cells – to deliver a protein called CD24 to the lungs, which Arber has been studying for decades.

“This protein is located on the surface of cells and has a well-known and important role in regulating the immune system,” researcher Shiran Shapira, who is part of Arber’s research team, told the Times of Israel earlier today.

Israeli media hail the results as “a huge breakthrough” and the hospital has reportedly reached out to the country’s Ministry of Health, requesting them for permission to extend and expand the trial.
https://www.cityam.com/israeli-hospital ... -recovery/
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

That's interesting
The Atheist
Posts: 1575
Joined: Fri Aug 04, 2006 9:22 pm
Location: Auckland

Re: SARS-CoV-2 vaccines

Post by The Atheist »

Anaxagoras wrote: Thu Feb 04, 2021 12:55 pm Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose
However, it appears to be ineffective against the SA variant, where they've suspended its use: https://www.washingtonpost.com/world/eu ... story.html
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

I wonder if we're going to need a new vaccine.

I assume that Pfizer and Moderna are already working on another one (or more).
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

Israel Won’t Reach Covid-19 Immunity Even If All Adults Jabbed

Apparently the vaccine has not been tested for children, so its use has only been approved for adults.

Not entirely sure why that would be the case, since lots of other vaccines are given to children. Maybe the thinking is that because children are at lower risk from the disease, they needn't be vaccinated? :notsure: But then, they could still be vectors.
Israel is unlikely to reach herd immunity from Covid-19 even if all adults are inoculated, because there is currently no vaccine that has been approved for children, Israel’s top public health official said on Sunday.

“The moment we have 2.5 million children that can’t be vaccinated, we probably won’t reach herd immunity, even if the entire population that can be vaccinated, will be vaccinated,” Sharon Alroy-Preis said at a parliamentary committee meeting.

More than a third of the 9.3 million people who live in Israel have had at least one dose of the Pfizer Inc.-BioNTech SE vaccine, and about one-fifth are fully vaccinated.
robinson
Posts: 16829
Joined: Sat Aug 12, 2006 2:01 am
Title: Sardonic asshole
Location: USA

Re: SARS-CoV-2 vaccines

Post by robinson »

Even if the children were vaccinated, there will be another strain

It will never be over
Pyrrho
Posts: 31974
Joined: Sat Jun 05, 2004 2:17 am
Title: Man in Black
Location: Division 6

Re: SARS-CoV-2 vaccines

Post by Pyrrho »

Just waiting my turn for infection here, Boss.
The Atheist
Posts: 1575
Joined: Fri Aug 04, 2006 9:22 pm
Location: Auckland

Re: SARS-CoV-2 vaccines

Post by The Atheist »

Anaxagoras wrote: Tue Feb 09, 2021 2:17 am Apparently the vaccine has not been tested for children, so its use has only been approved for adults.
I don't get that, either.

We know mutations are happening, and they will continue to happen while there are infections.

Plus, all the data I've seen regarding the UK and SA strains say they're more likely to infect children and youth.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Common asthma drug cuts COVID-19 hospitalization risk, recovery time - Oxford study

A commonly used asthma treatment appears to reduce the need for hospitalizations as well as recovery time for COVID-19 patients if given within seven days of symptoms appearing, researchers at the University of Oxford said on Tuesday.

The findings were made following a mid-stage study of the steroid budesonide, sold as Pulmicort by AstraZeneca Plc and also used for treating smoker’s lung.

The 28-day study of 146 patients suggested that inhaled budesonide reduced the risk of urgent care or hospitalization by 90% when compared with usual care, Oxford University said.

Researchers said the trial was inspired by the fact that patients with chronic respiratory disease, who are often prescribed inhaled steroids, were significantly under-represented among hospitalized COVID-19 patients during early days of the pandemic.

Initial data from the study also found volunteers treated with budesonide had a quicker resolution of fever and fewer persistent symptoms.
https://www.reuters.com/article/us-heal ... SKBN2A92DA
The Atheist
Posts: 1575
Joined: Fri Aug 04, 2006 9:22 pm
Location: Auckland

Re: SARS-CoV-2 vaccines

Post by The Atheist »

Witness wrote: Wed Feb 10, 2021 1:25 amResearchers said the trial was inspired by the fact that patients with chronic respiratory disease, who are often prescribed inhaled steroids, were significantly under-represented among hospitalized COVID-19 patients during early days of the pandemic.
This kind of thing is entirely due to a disgraceful lack of co-ordination.

I was way back in Wuhan that doctors on the ground saw fewer smokers and ex-smokers, and fewer asthma patients than they expected.

And it's taken 12 months to figure out why.

Still, more very good news on the treatment front - there's a bit of an array of steroids that appear to be working, and the good news about them is that unlike anti-virals, they don't affect the virus at all, so mutations won't matter.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

The Atheist wrote: Fri Feb 12, 2021 12:44 am the good news about them is that unlike anti-virals, they don't affect the virus at all, so mutations won't matter.
Good point. Could also be useful for the next, similar, virus. :|




Pfizer vaccine found to give strong immune response to new Covid variants

Study finds patients have strong T-cell response after one jab, and second boosts antibody response

People who have received two doses of the Pfizer vaccine have been found to have strong T-cell responses against the Kent and South African variants of Covid, suggesting that the vaccine will continue to protect against serious disease in the coming months.

In the first study to test immune responses against the variants circulating in populations, researchers found that although antibody responses against the new variants were blunted, they may still be high enough to protect most people from becoming infected, after a second dose of vaccine has been given.

Although previous studies had suggested that antibodies from those vaccinated with the Pfizer/BioNTech jab could recognise and neutralise viruses carrying some of the individual mutations found in the South African and Kent variants – albeit at slightly lower levels compared with previous variants – these were tested on engineered viruses rather than ones isolated from real patients.

These studies also did not look at T cells, which annihilate virus-infected cells and support the production of antibodies. Both immune responses help provide lasting protection after vaccination, but antibody responses are easier to measure.

William James, a professor of virology at the University of Oxford, and his colleagues took blood samples from people who had recovered from Covid-19, and health workers who had received either one or two doses of the Pfizer/BioNTech vaccine. They also obtained isolates of the B117 and B1.351 virus variants first identified in Kent and South Africa, and of an older variant similar to those circulating a year ago. Antibodies and T cells from the individuals were then tested against these viruses to see how well they performed.

The study, which has not yet been reviewed by other scientists, found that people’s antibodies were moderately effective against the original virus after their first dose of vaccine, less effective against the Kent variant, and were unable to neutralise the South African variant.

However, they had strong T-cell responses against all known variants after the first jab. “It may not necessarily protect you against infection, but it’s very likely that this first dose will make it much easier for your immune system to make a good response the next time around,” said James. “We think this is why that second dose produces such a good strong antibody response, because the T cells are already there, ready to react.”
https://www.theguardian.com/world/2021/ ... d-variants
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

The first people are being vaccinated in Japan. Seeing it live on TV.

They are starting with doctors and nurses of course.

Still, they are taking things very slowly. It seems that they are limiting the first group to 40,000 in what amounts to a kind of clinical trial, and mass vaccinations won't begin in earnest until April:

Japan to start administering COVID-19 vaccine to health workers
Japan is set to begin administering a COVID-19 vaccine on Wednesday to an initial group of 40,000 health workers, before expanding to cover the elderly and people with preexisting conditions.
Of the initial group, 20,000 will participate in a study to track side effects potentially caused by the vaccine developed by U.S. drugmaker Pfizer Inc. and Germany's BioNTech SE and the frequency with which they occur.

They will be asked to keep daily records for seven weeks after taking the first of two shots. The shots will be administered three weeks apart.
A further 3.7 million front-line health workers are to begin being inoculated in March, followed by 36 million people aged 65 or older from April.

People with preexisting conditions such as diabetes or heart disease and those working at elderly care facilities will come next, and then finally the general population.
So it appears that the rate of vaccinations will be very slow for the rest of this month and next month at least. They want to do their own study of the side effects
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

https://i.imgur.com/4GOEwkR.png
Pyrrho
Posts: 31974
Joined: Sat Jun 05, 2004 2:17 am
Title: Man in Black
Location: Division 6

Re: SARS-CoV-2 vaccines

Post by Pyrrho »

Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

https://www.bloomberg.com/graphics/covi ... tribution/
The biggest vaccination campaign in history is underway. More than 271 million doses have been administered across 108 countries, according to data collected by Bloomberg. The latest rate was roughly 6.36 million doses a day.

In the U.S., more Americans have now received at least one dose than have tested positive for the virus since the pandemic began. So far, 80.5 million doses have been given. In the last week, an average of 2.01 million doses per day were administered.
Vaccines Across America
Across the U.S., 24.3 doses have been administered for every 100 people, and 75% of the shots delivered to states have been administered.
The Path to Immunity in the U.S.
In the U.S., the latest vaccination rate is 2,010,790 doses per day, on average. At this rate, it will take an estimated 6 months to cover 75% of the population with a two-dose vaccine.
So they've managed to reach 2 million doses per day, which seems pretty good. Hopefully they can push it even higher than that.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Catholics in New Orleans and St Louis told to avoid Johnson & Johnson vaccine

Religious leaders in two cities say use of abortion-derived cells in development means believers should prefer Pfizer and Moderna
https://www.theguardian.com/world/2021/ ... on-vaccine
Pyrrho
Posts: 31974
Joined: Sat Jun 05, 2004 2:17 am
Title: Man in Black
Location: Division 6

Re: SARS-CoV-2 vaccines

Post by Pyrrho »

More for us then.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

AstraZeneca’s COVID-19 vaccine not recommended for people in Canada over age 65: NACI

Canada’s National Advisory Committee on Immunization (NACI) is not currently recommending the newly approved COVID-19 vaccine from AstraZeneca be used on people aged 65 or older.

According to the NACI website, this is “due to limited information on the efficacy of this vaccine in this age group at this time.”

However, the agency said the vaccine has “demonstrated an average efficacy of approximately 62 per cent in those aged 18-64 years of age.”

The vaccine received approval from Health Canada on Friday.

The NACI advice follows similar plans in many European countries. The European Medicines Agency said the vaccine could be used on all adults, but a number of countries decided not to use it for seniors because of the limited clinical data.

However, on Monday, French Health Minister Olivier Veran reversed course, saying the vaccine has been found to be very effective against the virus.

Further, Public Health England released data from a pre-print of a real-world study on Monday which said the AstraZeneca vaccine has been found to be “highly effective” in reducing infections among people 70 and older.

However, that study has not yet been peer reviewed.
https://globalnews.ca/news/7670304/coro ... nada-naci/
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

Vaccine data from Israel. I've been following the news there since they are pretty far ahead of anyone else in terms of percentage of their population that has been vaccinated already:

COVID-19 vaccination: 73 cases of facial paralysis, 7 anaphylactic shock (Jerusalem Post)
Serious symptoms of the vaccine include blurred vision, inflammation of the pulmonary pleura, inflammation of the heart, heart attack, or even liver damage.
The good news is that serious side effects seem to be relatively rare.
Only 153 people (.0.0032%) out of more than 4.7 million who received a first shot of the Pfizer coronavirus vaccine had any kind of serious side effects, according to a new report published by the Health Ministry.
Only 162 had serious side effects from the second dose out of 3.4 million.
The types of serious issues that people experienced ranged from blurred vision, inflammation of the pulmonary pleura (that allow optimal expansion and contraction of the lung during breathing), inflammation of the heart, heart attack or even liver damage.
Some 62 people were hospitalized after receiving their first dose; 75% of them had underlying medical conditions before getting the jab.
Forty-two people were hospitalized after the second shot.
Some 487 (first) and 250 (second) had neurological issues after getting inoculated: 474 people who experienced paresthesia (tingling, pricking, chilling, burning, numbness of the skin), 73 who had bell’s palsy (facial paralysis), 23 convulsions, 28 metal taste in the mouth, 14 loss of consciousness, five transient cerebral ischemia (temporary stroke) and 59 others who had unidentified neurological issues.
In total, there were 9,595 people who reported side effects of the vaccines out of 4,755,585 people who received the first dose, and another 8,743 out of 3,408,825 who received the second dose.
So are they approaching herd immunity yet? (According to the latest data, over 40% of Israelis have been fully vaccinated (both doses) so far.)
The answer seems to be not quite yet:

Only 100,000 Israelis over 50 left to be vaccinated - new data
The reproduction rate (R) has started to stabilize around the number one, worrying health officials who know that if the rate passes one infection will once again start to spread.
At the same time, despite warnings by the Coronavirus Knowledge and Information Center, there has not been any major outbreak.
The center warned in a Friday report that Israel could be on the verge of another outbreak, with the next stage of reliefs set to be rolled out on Sunday while around 5% of people tested per day have a positive result. Though it noted that even if the number of new cases increases, it is unlikely Israel will see a spike in serious cases due to vaccination.
According to Eran Segal, a computational biologist for the Weizmann Institute of Science, before vaccination, around 27% of new daily cases were 19 years or older and today around 47% of cases fall in that age range. In contrast, 25% of new cases were 50 years or older before the vaccines. Now, only 11% of new cases are in that age range.
So, at least the demographic data would seem to indicate that infections are at least falling among over-50s, the group that has mostly been vaccinated already, while it continues to spread among younger people, who are still waiting their turn.

Meanwhile the government has decided to further ease restrictions, and has a kind of "vaccine passport" system that allows people who have been fully vaccinated to eat in restaurants and such:

Coronavirus: Israel is opening on Sunday - here are the details
The country is opening up further on Sunday, according to a decision by the government. This is the third stage of Israel’s exit strategy.
While at first health officials were recommending slowing down Israel’s opening given the reproduction rate (R) that has been holding around one, the government decided to move forward. As such, more children will return to school and additional commerce and recreation will be available to the public.
Entry into many of the new offerings are subject to a green passport, which can be obtained through the Health Ministry for anyone who has been fully vaccinated with two shots for at least a week. Children under the age of 16, who are not allowed to be vaccinated, will not be able to accompany their vaccinated parents.
Restaurants and cafes - Green passport holders will be able to sit indoors or outdoors, non-vaccinated people will be able to sit outside. Restaurants and cafes will operate according to the Purple Ribbon outline.
Hotels - Will now open beyond the rooms and provide a full range of activities for green passport holders
Event halls, attractions, conferences - Open to green passport holders
So this "green passport" idea would seem to provide an additional incentive to people who might be hesitant to get vaccinated. You will need one if you want to eat indoors at a restaurant, for example.
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

Japan sees high rate of anaphylaxis after taking Pfizer vaccine
The health ministry later said an additional eight cases of anaphylaxis, a severe and potentially fatal allergic reaction, were reported, bringing the total to 25 among around 148,000 health care workers who have been inoculated as of Wednesday.

Among those who suffered anaphylaxis, 24 were women. The first male case was reported the same day.

The rate compares with five cases in every 1 million doses administered in the United States and 20 cases per million in Britain, although Japan is further behind in its vaccine rollout and it could change as more people receive shots.
Is that typical or a statistical fluke I wonder? 24/25 cases of anaphylaxis were in women. Maybe there were more women than men vaccinated but probably not to that extent.
Pyrrho
Posts: 31974
Joined: Sat Jun 05, 2004 2:17 am
Title: Man in Black
Location: Division 6

Re: SARS-CoV-2 vaccines

Post by Pyrrho »

These are the kinds of adverse events that can show up after a treatment is used outside of clinical trials. Taking a brief look at the FDA Briefing Document for the Pfizer vaccine...the demographics tables show that Asians were a small population in the overall study...thus it may be possible that Asians have a greater chance to suffer anaphylaxis, and that did not become evident during the study.

https://www.fda.gov/media/144245/download

Table 5 lists the demographics for the safety portion of the study. There were 1606 Asians in a study population of 37,586. I am not informed enough to know if that subgroup would have made it possible to have statistical significance in the safety analysis of adverse events.
ed
Posts: 41464
Joined: Tue Jun 08, 2004 11:52 pm
Title: G_D

Re: SARS-CoV-2 vaccines

Post by ed »

Witness wrote: Thu Mar 04, 2021 1:32 am
Catholics in New Orleans and St Louis told to avoid Johnson & Johnson vaccine

Religious leaders in two cities say use of abortion-derived cells in development means believers should prefer Pfizer and Moderna
https://www.theguardian.com/world/2021/ ... on-vaccine
Interesting that they haven't excommunicated Biden or Pelosi
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

NYT Coronavirus Tracker: https://www.nytimes.com/interactive/202 ... 0p19G=0232

Apparently there's a lot in the pipeline.
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

Some discouraging news:
More European nations pause AstraZeneca vaccine use as blood clot reports investigated
Denmark, Iceland and Norway have suspended the use of the Oxford-AstraZeneca Covid-19 vaccine while the European Union's medicines regulator investigates whether the shot could be linked to a number of reports of blood clots.
Denmark announced a two-week suspension on Thursday following a number of reports of clotting in the country, including one fatal case. Iceland and Norway followed suit, but did not say how long their suspensions would last.
Danish Health Minister Magnus Heunicke made clear the pause was a "precautionary measure," saying it was not possible yet to draw conclusions.

"We act early, it needs to be thoroughly investigated," he said in a tweet.

The Danish Health Authority also stressed that the decision was temporary.
"We are in the middle of the largest and most important vaccination rollout in Danish history. And right now we need all the vaccines we can get. Therefore, putting one of the vaccines on pause is not an easy decision. But precisely because we vaccinate so many, we also need to respond with timely care when there is knowledge of possible serious side effects. We need to clarify this before we can continue to use the vaccine from AstraZeneca," Søren Brostrøm, director of the National Board of Health, said in the statement.
Anaxagoras
Posts: 29660
Joined: Wed Mar 19, 2008 5:45 am
Location: Yokohama/Tokyo, Japan

Re: SARS-CoV-2 vaccines

Post by Anaxagoras »

The Bloomberg tracker says that 4.6 million shots were administered in the US yesterday (March 13th). That's a lot for one day.

https://www.bloomberg.com/graphics/covi ... tribution/

Average for the last week is 2.5 million/day. Worldwide 9.14 million/day
The biggest vaccination campaign in history is underway. More than 354 million doses have been administered across 121 countries, according to data collected by Bloomberg. The latest rate was roughly 9.14 million doses a day.

In the U.S., more Americans have received at least one dose than have tested positive for the virus since the pandemic began. So far, 106 million doses have been given. In the last week, an average of 2.54 million doses per day were administered.
Also, the US has passed 100 million doses.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Severe allergy added to AstraZeneca vaccine side effects: EU regulator

Severe allergies should be added to the possible side effects of AstraZeneca's coronavirus vaccine after likely links were found to a number of cases in Britain, the EU's drug regulator said on Friday.

The development comes a day after the European Medicines Agency said it was investigating a separate issue of blood clots that prompted Denmark to suspend use of the jab, but said it remained safe to use.

The Amsterdam-based EMA said it had "recommended an update to the product information to include anaphylaxis and hypersensitivity (allergic reactions) as side effects".

"The update is based on a review of 41 reports of possible anaphylaxis seen among around 5 million vaccinations in the United Kingdom," it said in the highlights of the EMA committee that assesses the risk of medications.

"After careful review of the data, (the committee) considered that a link to the vaccine was likely in at least some of these cases."

The EMA said however that anaphylaxis, or what it called "severe allergic reactions", was already what it called a "known side effect that may occur, very rarely, with vaccines".
https://medicalxpress.com/news/2021-03- ... ccine.html
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Exclusive: Regular booster vaccines are the future in battle with COVID-19 virus, top genome expert says

CAMBRIDGE, England (Reuters) - Regular booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, the head of Britain’s effort to sequence the virus’s genomes told Reuters.

The novel coronavirus, which has killed 2.65 million people globally since it emerged in China in late 2019, mutates around once every two weeks, slower than influenza or HIV, but enough to require tweaks to vaccines.

Sharon Peacock, who heads COVID-19 Genomics UK (COG-UK) which has sequenced nearly half of all the novel coronavirus genomes so far mapped globally, said international cooperation was needed in the “cat and mouse” battle with the virus.

“We have to appreciate that we were always going to have to have booster doses; immunity to coronavirus doesn’t last forever,” Peacock told Reuters at the non-profit Wellcome Sanger Institute’s 55-acre campus outside Cambridge.

“We already are tweaking the vaccines to deal with what the virus is doing in terms of evolution - so there are variants arising that have a combination of increased transmissibility and an ability to partially evade our immune response,” she said.

Peacock said she was confident regular booster shots - such as for influenza - would be needed to deal with future variants but that the speed of vaccine innovation meant those shots could be developed at pace and rolled out to the population.
https://www.reuters.com/article/us-heal ... SKBN2B70V2

Darwin never sleeps.
Witness
Posts: 35689
Joined: Thu Sep 19, 2013 5:50 pm

Re: SARS-CoV-2 vaccines

Post by Witness »

Moderna begins testing on its new COVID-19 vaccine candidate

Company says candidate could be stored, shipped in refrigerators instead of freezers

Moderna Inc. said on Monday it had dosed the first participant in an early-stage study of a new COVID-19 vaccine candidate that could potentially be stored and shipped in refrigerators instead of freezers.

The company said its new candidate could make it easier for distribution, especially in developing countries where supply chain issues could hamper vaccination drives.

The early-stage study will assess the safety and immunogenicity of the next-generation vaccine, designated as mRNA-1283, at three dose levels, and will be given to healthy adults either as a single dose, or in two doses 28 days apart, the company said.

Moderna also plans to evaluate the new vaccine, mRNA-1283, as a potential booster shot in future studies.

Last week, Moderna began dosing the first participants in a study testing COVID-19 booster vaccine candidates targeting the variant, known as B.1.351, that was first detected in South Africa.
https://www.cbc.ca/amp/1.5950322